Abstract

Mitochondrial dysfunction is central to the pathogenesis of various diseases. Acute kidney injury (AKI) is characterized by mitochondrial dysfunction and activation of the innate immune system. The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway detects cytosolic DNA and induces innate immunity. Here, we investigated the role of mitochondrial damage and subsequent activation of the cGAS-STING pathway using a genetically engineered animal model of cisplatin-induced AKI and cultured tubular cells. Cisplatin induced mitochondrial DNA (mtDNA) leakage into the cytosol in tubules with subsequent activation of the cGAS-STING pathway, thereby triggering inflammation and AKI progression, which was improved in STING -deficient mice. STING knockdown in cultured tubular cells ameliorated inflammatory responses induced by cisplatin. mtDNA depletion and repletion studies confirmed tubular inflammatory responses via the cGAS-STING signal activation by cytosolic mtDNA. Therefore, we concluded that mitochondrial dysfunction and subsequent activation of the mtDNA-cGAS-STING pathway is a critical regulator of kidney injury.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.